Updated
CyberMiles Bullish Signals | 400%+ Fully Mapped
CyberMiles (CMTBTC) is looking good with two major signals now taking place. We have the increasing trading volume as well as the challenge of EMA100.
On top of these two strong bullish signals, we can also see a bullish cross on the MACD, let's take a closer look:
Prices are still trading below MA200, once this level is conquered, you can expect a very nice and strong jump.
All targets fully marked on the chart with over 400% potential profits to our highest target... ENJOY!
Namaste.
On top of these two strong bullish signals, we can also see a bullish cross on the MACD, let's take a closer look:
Prices are still trading below MA200, once this level is conquered, you can expect a very nice and strong jump.
All targets fully marked on the chart with over 400% potential profits to our highest target... ENJOY!
Namaste.
Note
This one will move strong now.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.